These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25405889)

  • 41. Potential applications of microbial surfactants in biomedical sciences.
    Singh P; Cameotra SS
    Trends Biotechnol; 2004 Mar; 22(3):142-6. PubMed ID: 15036865
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Force Nanoscopy as a Versatile Platform for Quantifying the Activity of Antiadhesion Compounds Targeting Bacterial Pathogens.
    Beaussart A; Abellán-Flos M; El-Kirat-Chatel S; Vincent SP; Dufrêne YF
    Nano Lett; 2016 Feb; 16(2):1299-307. PubMed ID: 26812480
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pili in gram-positive pathogens.
    Telford JL; Barocchi MA; Margarit I; Rappuoli R; Grandi G
    Nat Rev Microbiol; 2006 Jul; 4(7):509-19. PubMed ID: 16778837
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recently approved and investigational antibiotics for treatment of severe infections caused by Gram-positive bacteria.
    Appelbaum PC; Jacobs MR
    Curr Opin Microbiol; 2005 Oct; 8(5):510-7. PubMed ID: 16098786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intervention with bacterial adhesion by multivalent carbohydrates.
    Pieters RJ
    Med Res Rev; 2007 Nov; 27(6):796-816. PubMed ID: 17022032
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro activity of tigecycline against multiple-drug-resistant, including pan-resistant, gram-negative and gram-positive clinical isolates from Greek hospitals.
    Souli M; Kontopidou FV; Koratzanis E; Antoniadou A; Giannitsioti E; Evangelopoulou P; Kannavaki S; Giamarellou H
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3166-9. PubMed ID: 16940120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria.
    Putnam SD; Castanheira M; Moet GJ; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):393-401. PubMed ID: 20022192
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design, synthesis and biological evaluations of novel 7-[3-(1-aminocycloalkyl)pyrrolidin-1-yl]-6-desfluoro-8-methoxyquinolones with potent antibacterial activity against multi-drug resistant Gram-positive bacteria.
    Miyauchi R; Kawakami K; Ito M; Matsuhashi N; Ohki H; Inagaki H; Takahashi H; Takemura M
    Bioorg Med Chem; 2009 Oct; 17(19):6879-89. PubMed ID: 19736016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of natural antimicrobials on bacterial cell hydrophobicity, adhesion, and zeta potential.
    Kurinčič M; Jeršek B; Klančnik A; Možina SS; Fink R; Dražić G; Raspor P; Bohinc K
    Arh Hig Rada Toksikol; 2016 Mar; 67(1):39-45. PubMed ID: 27092638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discovery of a potent phenolic N1-benzylidene-pyridinecarboxamidrazone selective against Gram-positive bacteria.
    Rathbone DL; Parker KJ; Coleman MD; Lambert PA; Billington DC
    Bioorg Med Chem Lett; 2006 Feb; 16(4):879-83. PubMed ID: 16298528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pleuromutilin derivatives having a purine ring. Part 2: influence of the central spacer on the antibacterial activity against Gram-positive pathogens.
    Hirokawa Y; Kinoshita H; Tanaka T; Nakamura T; Fujimoto K; Kashimoto S; Kojima T; Kato S
    Bioorg Med Chem Lett; 2009 Jan; 19(1):170-4. PubMed ID: 19028096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro evaluation of the antibacterial activity of three different central venous catheters against gram-positive bacteria.
    Yorganci K; Krepel C; Weigelt JA; Edmiston CE
    Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):379-84. PubMed ID: 12072923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Large molecules as anti-adhesive compounds against pathogens.
    Wittschier N; Lengsfeld C; Vorthems S; Stratmann U; Ernst JF; Verspohl EJ; Hensel A
    J Pharm Pharmacol; 2007 Jun; 59(6):777-86. PubMed ID: 17637170
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Different Use of Cell Surface Glycosaminoglycans As Adherence Receptors to Corneal Cells by Gram Positive and Gram Negative Pathogens.
    García B; Merayo-Lloves J; Rodríguez D; Alcalde I; García-Suárez O; Alfonso JF; Baamonde B; Fernández-Vega A; Vazquez F; Quirós LM
    Front Cell Infect Microbiol; 2016; 6():173. PubMed ID: 27965938
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new antibiotic and the evolution of resistance.
    Arias CA; Murray BE
    N Engl J Med; 2015 Mar; 372(12):1168-70. PubMed ID: 25785976
    [No Abstract]   [Full Text] [Related]  

  • 56. Is bacterial fatty acid synthesis a valid target for antibacterial drug discovery?
    Parsons JB; Rock CO
    Curr Opin Microbiol; 2011 Oct; 14(5):544-9. PubMed ID: 21862391
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extracellular Matrix Interactions with Gram-Positive Pathogens.
    Hammerschmidt S; Rohde M; Preissner KT
    Microbiol Spectr; 2019 Mar; 7(2):. PubMed ID: 31004421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Small Molecules That Sabotage Bacterial Virulence.
    Johnson BK; Abramovitch RB
    Trends Pharmacol Sci; 2017 Apr; 38(4):339-362. PubMed ID: 28209403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting the bacteria-host interface: strategies in anti-adhesion therapy.
    Krachler AM; Orth K
    Virulence; 2013 May; 4(4):284-94. PubMed ID: 23799663
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Towards Gram-positive antivirulence drugs: new inhibitors of Streptococcus agalactiae Stk1.
    Oxoby M; Moreau F; Durant L; Denis A; Genevard JM; Vongsouthi V; Escaich S; Gerusz V
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3486-90. PubMed ID: 20529681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.